Fennec Pharmaceuticals Announces First Quarter 2022 Financial Results and Provides Business Update
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Source: apnews.com
Page 2 - First Therapy News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from First Therapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In First Therapy Today - Breaking & Trending Today
FENNEC PHARMACEUTICALS : RESUBMITS NEW DRUG APPLICATION TO U.S. FOOD AND DRUG ADMINISTRATION FOR PEDMARKTM
~ If Approved by the FDA, PEDMARK Stands to Be the First Therapy for the Prevention of Cisplatin-Induced Hearing Loss in Children ~ Research Triangle Park, NC, May 28 , 2021 - Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a specialty pharmaceutical company, today announced the resubmission of its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for PEDMARK TM (a unique formulation of sodium thiosulfate) for the prevention of ototoxicity induced by cisplatin chemotherapy in patients one month to The resubmission for PEDMARKfollows receipt of final minutes from...
Source: marketscreener.com